Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$810M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$745M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$671M |
| 4 |
Boeing
BA
|
+$390M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$784M |
| 2 |
NVIDIA
NVDA
|
+$532M |
| 3 |
Apple
AAPL
|
+$491M |
| 4 |
Amazon
AMZN
|
+$438M |
| 5 |
Newmont
NEM
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Financials | 11.26% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 8.25% |
| 5 | Consumer Discretionary | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
ChargePoint
CHPT
$142M
| $61.4K | ﹤0.01% |
2,868
+1,954
| +214% | +$48.4K |
|
|
LX
3927
LexinFintech Holdings
LX
$246M
| $60.6K | ﹤0.01% |
+10,455
| New | +$43.9K |
|
3928
Humacyte
HUMA
$181M
| $58.4K | ﹤0.01% |
+11,555
| New | +$57.2K |
|
|
YALA
3929
Yalla Group
YALA
$817M
| $56.4K | ﹤0.01% |
13,895
+1,242
| +10% | +$5.34K |
|
3930
Gabelli Equity Trust
GAB
$1.76B
| $55.7K | ﹤0.01% |
10,361
-2,190
| -17% | -$12.1K |
|
3931
ICL Group
ICL
$6.69B
| $55.1K | ﹤0.01% |
11,150
-823
| -7% | -$3.68K |
|
3932
Perspective Therapeutics
CATX
$341M
| $54.7K | ﹤0.01% |
17,326
-645,170
| -97% | -$5.27M |
|
|
URG
3933
Ur-Energy
URG
$497M
| $53.8K | ﹤0.01% |
+46,817
| New | +$57.8K |
|
3934
Q32 Bio
QTTB
$462M
| $53.5K | ﹤0.01% |
+15,548
| New | +$491K |
|
3935
Talkspace
TALK
$873M
| $53.1K | ﹤0.01% |
+17,175
| New | +$52.2K |
|
3936
Porch Group
PRCH
$1.57B
| $51K | ﹤0.01% |
+10,358
| New | +$33.3K |
|
3937
Opendoor
OPEN
$3.69B
| $49.8K | ﹤0.01% |
32,190
-226,574
| -88% | -$411K |
|
3938
CEMIG Preferred Shares
CIG
$6.21B
| $49.5K | ﹤0.01% |
27,787
-19,011
| -41% | -$36.9K |
|
3939
Beamr Imaging
BMR
$18.9M
| $49.2K | ﹤0.01% |
+10,000
| New | +$33.9K |
|
3940
BRC Inc
BRCC
$119M
| $46.6K | ﹤0.01% |
+14,692
| New | +$45.9K |
|
3941
Cardlytics
CDLX
$22.1M
| $45.9K | ﹤0.01% |
1,236
-150
| -11% | -$5.74K |
|
3942
Inter&Co
INTR
$2.49B
| $44.5K | ﹤0.01% |
10,556
-23,950
| -69% | -$134K |
|
|
NRO
3943
Neuberger Real Estate Securities Income Fund Inc
NRO
$193M
| $44.5K | ﹤0.01% |
13,123
+2,268
| +21% | +$8.24K |
|
3944
Oxbridge Re Holdings
OXBR
$10.6M
| $41.2K | ﹤0.01% |
10,000
| – | – |
|
3945
Cerus
CERS
$579M
| $40.5K | ﹤0.01% |
+26,268
| New | +$45.2K |
|
3946
Taysha Gene Therapies
TSHA
$1.69B
| $39.8K | ﹤0.01% |
+22,993
| New | +$47.7K |
|
3947
Ambev
ABEV
$48.2B
| $39.6K | ﹤0.01% |
21,337
-3,428
| -14% | -$7.58K |
|
3948
Beyond Meat
BYND
$286M
| $38.9K | ﹤0.01% |
+10,343
| New | +$54.9K |
|
3949
ImmunityBio
IBRX
$7.8B
| $38.4K | ﹤0.01% |
+15,014
| New | +$62.5K |
|
|
FLNA
3950
Filana Therapeutics
FLNA
$46.4M
| $37.7K | ﹤0.01% |
15,973
-1,963
| -11% | -$34.5K |
|
Similar funds
Ameriprise's Q4 2024 Portfolio in Review
As of Q4 2024, Ameriprise held 4,210 positions worth $390B, down 0.05% from $390B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q4 2024 filing shows 290 new, 1,777 increased, 1,865 reduced and 140 closed positions. Its largest new stake was Primo Brands: 2,607,261 shares worth $80.2M. The largest sale was Elevance Health, an estimated $784M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2024 buy was Primo Brands: 2,607,261 shares worth $80.2M.
- Ameriprise added most to iShares Core US Aggregate Bond ETF in Q4 2024, an estimated $810M increase.
- Ameriprise's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $784M.
- Ameriprise fully exited Primo Water Corporation in Q4 2024, selling an estimated $62.3M.
- Ameriprise's ten largest holdings make up 21% of its $390B portfolio in Q4 2024.
- Ameriprise opened 290 new positions and closed 140 in Q4 2024.
- Ameriprise's portfolio value fell 0.05% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.